HER2-Positive Gastric Cancer

被引：0
|
作者：
Haralabos Demetriades
机构：
[1] Aristotle University of Thessaloniki,4th Surgical Department
来源：
Annals of Surgical Oncology | 2011年 / 18卷
关键词：
Gastric Cancer; Trastuzumab; Gastric Cancer Patient; Adjuvant Setting; HER2 Status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：190 / 191
页数：1
相关论文
共 50 条
  • [41] Advanced HER2-positive gastric cancer: Current and future targeted therapies
    Pazo Cid, Roberto A.
    Anton, Antonio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (03) : 350 - 362
  • [42] Hopes and failures in front-line advanced HER2-positive gastric cancer therapy
    Kong, Fanming
    Yao, Yang
    Deng, Renfen
    Li, Xiaojiang
    Jia, Yingjie
    ANTI-CANCER DRUGS, 2021, 32 (07) : 675 - 680
  • [43] Advances in the Management of HER2-positive Advanced Gastric and Gastroesophageal Junction Cancer
    Bang, Yung-Jue
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2012, 46 (08) : 637 - 648
  • [44] Antitumor activity of afatinib or neratinib in HER2-positive gastric cancer cells
    Yoshioka, Takahiro
    Shien, Kazuhiko
    Takahashi, Yuta
    Kurihara, Eisuke
    Namba, Kei
    Torigoe, Hidejiro
    Sato, Hiroki
    Yamamoto, Hiromasa
    Soh, Junichi
    Asano, Hiroaki
    Tsukuda, Kazunori
    Fujiwara, Toshiyoshi
    Toyooka, Shinichi
    CANCER SCIENCE, 2018, 109 : 738 - 738
  • [45] Phase II trial of dacomitinib in patients with HER2-positive gastric cancer
    Do-Youn Oh
    Kewn-Wook Lee
    Jae Yong Cho
    Won Ki Kang
    Seock-Ah Im
    Jin Won Kim
    Yung-Jue Bang
    Gastric Cancer, 2016, 19 : 1095 - 1103
  • [46] Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab
    Kyunghye Bang
    Jaekyung Cheon
    Young Soo Park
    Hyung-Don Kim
    Min-Hee Ryu
    Yangsoon Park
    Meesun Moon
    Hyungeun Lee
    Yoon-Koo Kang
    Gastric Cancer, 2022, 25 : 794 - 803
  • [47] An anti-HER2 antibody conjugated with monomethyl auristatin E is highly effective in HER2-positive human gastric cancer
    Li, Hongwen
    Yu, Chao
    Jiang, Jing
    Huang, Changjiang
    Yao, Xuejing
    Xu, Qiaoyu
    Yu, Fang
    Lou, Liguang
    Fang, Jianmin
    CANCER BIOLOGY & THERAPY, 2016, 17 (04) : 346 - 354
  • [48] Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer
    Topcu, Atakan
    Atci, Muhammed Mustafa
    Secmeler, Saban
    Besiroglu, Mehmet
    Ayhan, Murat
    Ozkan, Metin
    Bozkurt, Oktay
    Urakci, Zuhat
    Ay, Seval
    Geredeli, Caglayan
    Yasin, Ayse Irem
    Turk, Haci Mehmet
    FUTURE ONCOLOGY, 2021, 17 (31) : 4157 - 4169
  • [49] Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancer
    Yuko Takano
    Satoshi Furune
    Yuki Miyai
    Sachi Morita
    Megumi Inoue
    Tomoya Shimokata
    Mihoko Sugishita
    Ayako Mitsuma
    Osamu Maeda
    Yuichi Ando
    International Cancer Conference Journal, 2022, 11 : 67 - 70
  • [50] Trastuzumab deruxtecan and other HER2-targeting agents for the treatment of HER2-positive gastric cancer
    Ishii, Takahiro
    Shitara, Kohei
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (11) : 1193 - 1201
12345